The General Pharmaceutical Council (GPhC) has raised concerns over the rising risks related to online pharmacy services.
It revealed over 30 per cent of its open Fitness to Practise (FtP) cases were related to online pharmacy, which is disproportionate to the sector of the market that
online services occupy.
The regulator has advised pharmacists and pharmacy owners providing online services that they should "not work with online providers who try to circumvent the
regulatory oversight put in place within the UK to ensure patient safety".
In the past five months, the Council has imposed seven interim orders on the registration of pharmacists who have worked for or with online prescribing services -
after identifying serious concerns with their practice.
It said: "These pharmacists were working as pharmacist independent prescribers for online services or were dispensing medicines prescribed online. Some of these
pharmacists were the Responsible Pharmacist (RP) or the Superintendent Pharmacist (SP)."
NHS England and NHS Improvement (NHSE&I), in association with the Royal Pharmaceutical Society (RPS) and the Association of Pharmacy Technicians UK (APTUK),
has published its first inclusive pharmacy practice (IPP) bulletin, with an overarching ambition "to make community pharmacy a more inclusive environment for all
pharmacy professionals".
The IPP programme will take practical steps to improve the awareness and understanding at all levels of different cultural beliefs and attitudes, according to the
Pharmaceutical Services Negotiating Committee (PSNC).
As a member of the IPP Improving Practice and Engagement Group, PSNC has contributed to this issue of the Bulletin, which focuses on how pharmacy professionals can
help to reduce health inequalities via the detection and prevention of cardiovascular diseases.
The IPP programme, of which the Bulletin forms a part, aims to engage with local communities to help improve their health and reduce inequalities in care -
particularly among those from ethnically diverse and disadvantaged backgrounds.
Pharmacists from BAME backgrounds still face higher levels of discrimination, harassment, bullying, and career obstacles compared to their white
counterparts, the Pharmacy Workforce Race Equality Standard (PWRES) report has revealed. Published by NHSE England, this report underscores the persistent
presence of inequality, emphasising the crucial need for all stakeholders in the pharmacy sector to prioritise addressing these issues.
The PWRES report indicates that pharmacy team members of Black ethnic backgrounds are less likely to perceive equal opportunities for career advancement or
promotion within their trust. Additionally, female pharmacy team members from BAME backgrounds report higher incidents of personal discrimination in the
workplace. The report also highlights an overrepresentation of pharmacy technicians from BAME backgrounds in lower-paid roles.
"It is shocking and unacceptable to see that across all indicators the BME staff experience is worse than their white counterparts," said Tase Oputu, Chair
of RPS in England.
The Pharmacy Supervision Practice Group consisting of members from AIMp, APTUK, CCA, NPA, PDA, PFNI and RPS held its fourth workshop to continue discussions
on the future modelling of pharmacy practice.
The ideas around 'supervision' shared by the organisation earlier formed the basis of the discussion during the workshop and helped to expand understanding of where
there was consensus and disagreement.
Examples of ideas explored during the workshop include: the extent to which a pharmacist should supervise the medicines assembly process, the purpose and extent to
which a pharmacist might be absent from the pharmacy and how this might affect patient safety as well as the nature of whether fixed rules versus a broad framework
were preferable for future practice.
Chair of the group, Dr Michael Twigg, Associate Professor of Primary Care Pharmacy, University of East Anglia, said "Once again the sector bodies have come together
in a collaborative and positive manner to explore the concept of 'supervision' in the context of current and future community pharmacy practice. This session provided an opportunity to constructively challenge assumptions and viewpoints within the group with the aim of moving the discussion forward."
As part of the session, the DHSC, GPhC and PSNI gave an overview of the difference between legislation, regulation and guidance which was helpful to inform the
group's thinking. Each of the organisations have been asked to use the conversation to refine the ideas presented in advance of the next workshop.
The Royal Pharmaceutical Society's (RPS) second roundtable on workforce wellbeing resulted in a series of collaborative actions to address pharmacy
professionals' mental health and wellbeing challenges.
The roundtable brought together key stakeholders from the pharmacy sector, including organisations like the General Pharmaceutical Council (GPhC), Community
Pharmacy England (CPE), the National Pharmacy Association (NPA), and the profession's independent charity Pharmacist Support (PS).
A report detailing the outcomes of the meeting was published on Friday, highlighting the key areas of discussion and the agreed-upon actions by the participants.
During the roundtable, participants discussed the importance of understanding the workforce demographics, both nationally and locally, and using data to address
wellbeing issues effectively.
They also emphasised the need for using supportive standards set by the General Pharmaceutical Council (GPhC) and the Care Quality Commission (CQC) quality
statement to support and empower pharmacists' wellbeing positively.
Extending its support for the Prescription Charges Coalition (PCC), the Pharmacists' Defence Association (PDA) is asking pharmacists in England to share their
experiences of patients denying prescriptions due to financial issues.
PDA members who have practiced in the country within the last 12 months are asked to complete the Prescription Charges Coalition survey by Sunday 28 January.
The PCC is an alliance of more than 50 organisations campaigning to abolish unfair prescription charges for people with long-term conditions in England.
All members of the coalition, including PDA and Royal Pharmaceutical Society (RPS), understand that if patients do not receive their prescribed medicines due to the
cost, their health may deteriorate, and this can increase costs for the National Health Service (NHS).
More than a third of pharmacists who participated in a survey said they have seen an increase in patients declining prescriptions due to the cost in the
last 12 months.
The survey was jointly conducted by the Pharmacists' Defence Association (PDA) and the Royal Pharmaceutical Society (RPS), extending their support for the
Prescription Charges Coalition (PCC).
Responding to the survey, 90 per cent of pharmacists admitted seeing cases where patients decline all the medicines on a prescription due to cost.
Nearly all respondents said they have seen cases where patients declined some of their prescribed medicines and more than a quarter of them have experienced
such situation often.
They have warned of the impact of prescription charges as patients are denying vital medicines, including those for blood pressure and mental health, inhalers,
antibiotics, pain relief, and statins, which can have potential consequences for the individual's health.
Campaigners have submitted an open letter to the Department of Health and Social Care (DHSC), urging the Minister for Primary Care and Public Health to
freeze prescription charges to keep people with long-term conditions alive and well.
The campaign is led by the Prescription Charges Coalition, which represents over 50 organisations, including Royal Pharmaceutical Society (RPS) and Pharmacists'
Defence Association (PDA).
Currently, the prescription charge is £9.65 per item, and campaigners have asked the government to freeze it for 2024 and 2025 as people living with long-term
health conditions in England are "being forced to choose between heating, eating, and taking their vital medication on a daily basis."
In 2023, a study conducted by the Prescription Charges Coalition revealed that almost 10 per cent of survey participants had skipped medication in the previous
year due to the cost of prescriptions. This led to increased physical and mental health problems, as well as impacted the time they took off work.
Laura Cockram, Chair of the Prescription Charges Coalition and Head of Campaigns at Parkinson's UK, expressed deep concern that a further rise in the charge this
year will lead to people skipping or not taking the full dose of their medication, which will affect their health and put more pressure on the already under
pressure NHS.
Community Pharmacy England (CPE), the Company Chemists' Association (CCA), the Royal Pharmaceutical Society (RPS) and the National Pharmacy Association
(NPA) on Tuesday (5 March) released a joint manifesto for community pharmacy in anticipation of the upcoming general election expected later this year.
The manifesto has been designed for widespread use within the community pharmacy sector to facilitate engagement with political parties and parliamentary candidates.
In their #VotePharmacy manifesto, the pharmacy bodies have highlighted a robust six-point plan to unleash the potential of pharmacy.
Election candidates are urged to express their support in six key areas, which include:
Filling the funding gap and committing to long-term sustainable funding to empower pharmacies to deliver more NHS care.
Enhancing the community pharmacy workforce to ensure they can meet the evolving needs of patients.
A judicial review claim launched by the British Medical Association (BMA) against the General Medical Council (GMC) has parallelly intensified Pharmacists'
Defence Association's (PDA) scrutiny over the use of the term 'pharmacy professionals'.
PDA has criticised the evolving definition of 'pharmacy professionals,' and the potential risks to patient safety amidst regulatory ambiguity as part of "a far
wider agenda."
Concerns stem from what the PDA perceives as a blurring of distinctions between pharmacists and pharmacy technicians as "attempted homogenisation" by bodies like
the General Pharmaceutical Council (GPhC), NHS, and Royal Pharmaceutical Society (RPS).
Raising similar issue as the BMA against the GMC over its use of 'medical professionals for doctors and Medical Associate Professions (MAPs), Mark Koizol,
Chairman of the PDA has said:
A tribunal has ordered Boots to pay over £58,000 in compensation and costs to a pharmacist who was racially profiled at work.
S.Famojuro, a black pharmacist of Nigerian national origin, experienced racial harassment from pharmacy team members during a shift on 18 July 2020.
The Pharmacists' Defence Association (PDA), the independent trade union for pharmacists, represented the pharmacist throughout the internal grievance processes
and at the Employment Tribunal hearing.
In a detailed written judgment, the pharmacy team members and company managers were heavily criticised by the Tribunal, after finding that a pre-registration
pharmacy technician and a pharmacy advisor had undermined Famojuro in his professional role as the Responsible Pharmacist (RP) and insulted him.
The pharmacist lodged a grievance with Boots regarding his treatment, but it took the company over four months to initiate the investigation and set a meeting
date, and this was only done after the PDA intervened to address the unacceptable delays.
Maxine McCabe has made history as the first community pharmacist in the UK to be credentialed as a core advanced pharmacist by the Royal Pharmaceutical
Society (RPS) in Scotland.
Announcing McCabe's achieving, NHS Education for Scotland (NES) stated that this credential demonstrates her expertise across the four pillars of advanced practice:
clinical, leadership and management, educating others and research.
Maxine has worked in the community pharmacy sector since qualifying as a pharmacist in 2008, consistently showing a keen interest in developing the wider pharmacy
team and enhancing clinical services for the local patient population.
Throughout her career, she has managed various community pharmacies, including Boots and Parkhead Health Centre Pharmacy, where she played a crucial role in
developing pharmacy practice and nurturing pharmacy support roles and trainee pharmacists.
In 2023, Maxine took on a part-time role as a Senior Educator in the Prescribing & Clinical Skills teams at NHS Education for Scotland (NES). She continues to
practice as a pharmacist, leading the Teach and Treat Training Hub at Burnside Pharmacy in Lanarkshire.
McCabe expressed her excitement about the recognition, saying, "I am delighted to obtain my Advanced Practice credential and showcase that this is achievable in
community pharmacy."
The General Pharmaceutical Council (GPHC), Royal Pharmaceutical Society (RPS), Company Chemists Association (CCA), Association of Pharmacy
Technicians UK (APTUK), National Pharmacy Association (NPA), Guild of Healthcare Pharmacists, Pharmacists' Defence Association (PDA), and Independent
Pharmacies Association (IPA) have released a joint statement in response to the far-right riots across the UK.
They emphasised their united stance, declaring zero tolerance for racism towards colleagues or the public in any form.
The joint statement reads: "We are shocked and saddened by the violent public disorder events in recent days.
"We acknowledge how all sectors of the pharmacy profession may be impacted and recognise the challenges that this level of overt aggression can have on
people's ability or willingness to live their daily lives.
"The pharmacy workforce deserves peace and safety, not fear and harm. We stand united in having a zero tolerance of racism towards our colleagues or the
public in whatever form it takes."
Meanwhile, Community Pharmacy England (CPE) has expressed concerns that protests and violent disorder in various towns and cities across England may impact
the ability of community pharmacies to operate.
In a unified effort to improve women's healthcare, four leading organisations-the Company Chemists' Association (CCA), the National Pharmacy Association (NPA),
the Royal Pharmaceutical Society (RPS), and the Faculty of Sexual and Reproductive Healthcare (FSRH)-are calling for the commissioning of a National Emergency
Hormonal Contraception (EHC) service in England.
They are proposing that this service be provided free of charge through community pharmacies to women of all ages across the country.
They emphasised that such a service would "not only transform access to care for all women, but directly tackle health inequalities and vastly improve health
outcomes."
Cervical screening is one of the best ways to protect women from cervical cancer, which claims nearly two lives daily in England, according to NHS England.
Therefore, all women and those with a cervix between the ages of 25 and 64 are encouraged to attend cervical screening when invited.
Sadly, 3 in 10 of those eligible for cervical screening do not take up the potentially life-saving offer, as revealed by the NHS Cervical Screening Programme,
England 2022-2023 annual report.
Pharmacist Thorrun Govind, also a Healthcare Lawyer (Brabners LLP), underscores the significant role pharmacists and pharmacy teams can play in promoting cervical
cancer screening.
The former Chair of the Royal Pharmaceutical Society (RPS) in England told Pharmacy Business: "Pharmacists and pharmacy teams are a trusted part of the local
community. They therefore have a key part in promoting cervical cancer screening."
A BBC investigation has found 20 UK online pharmacies selling prescription-only medicines without adhering to the regulatory standards, such as checking
for GP approval or patient's medical records.
The news organisation was able to purchase over 1,600 restricted pills, including anti-anxiety drug, painkiller and sleeping medication, from these regulated
online pharmacies easily by providing false information.
However, the report didn't mention the names of the drugs as "they can be dangerous when taken without medical guidance."
Some pharmacies were also found selling high-risk and potentially addictive medicines, including benzodiazepines and antidepressants, based on online questionnaires
and did not require further checks.
The General Pharmaceutical Council (GPhC), which regulate online pharmacies in the UK, states that selling and supplying medicines at a distance brings
"different risks which need to be appropriately managed to protect patient safety."
The NHS England last week released a survey report on the involvement of pharmacy professionals in research, and proposed the implementation of a
clinical academic training pathway for pharmacy professionals by 2030.
Recommendations were made to support the embedding of research at all stages of a pharmacy professional's career.
The report presented the findings of two surveys that NHS England launched in May 2022, one for individual pharmacy professionals and one for organisations,
calling for evidence on clinical academic careers in pharmacy.
The survey found that only a minority of the pharmacy workforce take up clinical research training opportunities.
"Just under a quarter of individual respondents had applied for the National Institute of Health and Care Research (NIHR) or other research project grants, and
just under half of the organisational survey respondents had supported individuals to apply for such a grant," it said.
